Inwardly rectifying potassium (Kir) channels are expressed in many cell types and contribute to a wide range of physiological processes. Particularly, Kir4
Introduction
The inwardly rectifying potassium (Kir) channels comprise a superfamily composed of seven subfamilies (Kir1-7) containing at least 16 members in mammals. Kir channels play critical roles in the regulation of multiple cellular functions including repolarization of action potentials, K + homeostasis and hormone secretion (Hibino et al., 2010; Swale et al., 2014) . Among the Kir family, the Kir4.1 subunit is predominantly expressed in brain astrocytes mediating, at least partly, the astroglial spatial K + buffering (Neusch et al., 2006; Kucheryavyk et al., 2007) . This process unidirectionally transports excess extracellular K + to the regions of low K + (Simard and Nedergaard, 2004) . Additionally, Kir4.1 channels are expressed in the renal epithelia (Lourdel et al., 2002; Lachheb et al., 2008) , where they are responsible for the basolateral K + recycling in the distal tubules (Palygin et al., 2016 ).
The reduced expression or dysfunction of Kir4.1 channels seems to be involved in several diseases (Loudon and Fry, 2014; Nwaobi et al., 2016) . Recent studies showed that loss-offunction mutations of the human gene (KCNJ10) encoding Kir4.1 channels are responsible for the SeSAME/EAST syndrome, an autosomal recessive disorder characterized by seizures, sensorineural deafness, ataxia, intellectual disability and electrolyte imbalance (Bockenhauer et al., 2009; Scholl et al., 2009; Reichold et al., 2010) . Genetic variations of KCNJ10 have also been related to epilepsy Ferraro et al., 2004; Lenzen et al., 2005; Dai et al., 2015) , a group of neurological diseases characterized by seizure disorders. Other diseases associated to Kir4.1 channels include spinocerebellar ataxia (Gilliam et al., 2014) , autism (Sicca et al., 2011) , Alzheimer disease (Wilcock et al., 2009) , and Huntington disease (Tong et al., 2014) . Despite Kir4.1 channels appear an essential protein implicated in several key astrocytic and renal functions, pharmacological studies of these channels are limited. The glucocorticoid dexamethasone and the antibiotic minocycline have been shown to increase the expression of Kir4.1 channels (Zhao et al., 2011; Zhang et al., 2011) . Dexamethasone increases the expression of Kir4.1 channels by twofold in healthy retina and prevents the loss of these channels in inflamed retina (Zhao et al., 2011) , whereas minocycline rescues the levels of Kir4.1 channels in diabetic rat retinas (Zhang et al., 2011) . There are also a few studies reporting inhibition of Kir4.1 channels by several drugs (Su et al., 2007; Ohno et al., 2007; Furutani et al., 2009 , Rodríguez-Menchaca et al., 2016 . It has been speculated that inhibition of Kir4.1 channels by antidepressants may increase the neuronal activity by reducing the astroglial K + buffering, which could be involved in their clinical effects for depression . Although targeting Kir4.1 channels may be beneficial in certain conditions as mentioned above, their chronic inhibition could lead to unwanted effects, similar to those observed in patients presenting loss-of-function mutations on Kir4.1 channels. Therefore, a better understanding of the mechanisms of drug actions on Kir4.1 channels will enable the design of safer and effective drugs to treat Kir4.1 related diseases.
In this work, we evaluated the inhibition of Kir4.1 channels by quinacrine, an old antimalarial drug that has gained broad attention in drug-repositioning studies since it has been shown to possess anti-cancer properties (Neznanov et al., 2009; Preet et al., 2012; Khurana et al., 2015; Ericksson et al., 2015; Das et el., 2016) . Here, we show that quinacrine plugs the central cavity of Kir4.1 channels in a voltage-dependent manner and with slow blocking and unblocking kinetics.
Results

Inhibition of Kir4.1 channels by quinacrine
The effect of quinacrine was examined using the whole-cell configuration of the patch clamp technique in HEK293 cells transfected with Kir4.1 cDNA. The cells were held at −35 mV and voltage step-pulses (1 s in duration) were successively applied from −120 mV to +60 mV (with 20 mV increments) every 10 s. Each drug concentration was perfused until the steady-state effect was achieved (4-6 min). In control conditions (Fig. 1A and B, left) , Kir4.1 currents displayed their characteristic mild inward rectification. In the presence of quinacrine ( Fig. 1A and B, right) outward currents were almost completely reduced, whereas some inward currents were still observed. In fact, at negative voltages to E K , a slow recovery from block was observed during hyperpolarizing pulses, which suggests that quinacrine slowly dissociates from the channels at these voltages. The normalized current-voltage (I-V) relationships for currents measured at the end of the test pulse are shown in Fig. 1C . Quinacrine inhibited Kir4.1 in a concentration-and voltage-dependent manner.
In order to follow the apparent quinacrine dissociation from Kir4.1 channels, a double pulse protocol was used: the cell was first depolarized to +60 mV for 2 s followed by a long (20 s) hyperpolarizing pulse to −140 mV. During depolarization, Kir4.1 currents were strongly inhibited by quinacrine (30 μM) as expected, but the longer hyperpolarizing pulse induced a recovery of the inward currents that in some cells was almost complete (Fig. 1D) . However, in other cells the recovery was only partial at 30 μM and higher concentrations (data not shown). These results demonstrate that quinacrine blocks the channels during depolarization and slowly dissociates from the channels during repolarization.
Effect of quinacrine on Kir4.1 inside-out patches
Since virtually all of the known Kir4.1 channels blockers have access to the channels from the cytoplasm (polyamines, Mg 2+ , antidepressants, chloroethylclonidine), we tested the effect of quinacrine in excised inside-out patches, applying the drug directly to the intracellular side of the membrane. To evoke the currents, from a holding potential of −80 mV, a 50 s test pulse to +80 mV was applied followed by a 45 s repolarization to −80 mV. In this configuration, the stady-state effect was fast and it was already established at the first recording made at 10 s of the drug perfusion. Fig. 2A -C shows representative Kir4.1 current traces in the absence (control) and presence of 1 (A), 10 (B) and 100 μM (C) quinacrine. Under control conditions, in absence of Mg 2+ and polyamines, large outward and inward currents were observed. Application of quinacrine induced a concentration-dependent decrease of outward currents, whereas a slow and complete recovery from block was observed after the membrane potential was returned to −80 mV. These results suggest that quinacrine have access to Kir4.1 channels from the cytoplasm. Fig. 2D shows the concentration-dependent effects of quinacrine on Kir4.1 channels at +80 mV, the drug blocked the Kir4.1 outward currents with an IC50 of 1.8 ± 0.3 μM and a Hill coefficient of 0.97 ± 0.1.
Blocking and unblocking kinetics of quinacrine on Kir4.1 channels
We next examined the kinetics of block and unblock of quinacrine on Kir4.1 channels from inside-out recordings like those shown in the inset of Fig. 3A . We analyzed the blocking and unblocking kinetics at concentrations 30 and 100 μM. The time courses of the quinacrine effect during the depolarizing and hyperpolarizing steps were obtained by dividing the current recorded in the presence of the drug by the control current (I drug /I control ). These current ratios were fitted to a double and single exponential function to obtain the blocking and unblocking time constants (Fig. 3A) . The results are summarized in Fig. 3B and C. The blocking kinetics shows concentration dependence, whereas the unblocking kinetics was not significantly different at 30 and 100 μM, suggesting that quinacrine binds either to a single site in the intracellular face of Kir4.1 channels or to multiple sites with similar unblocking kinetics.
The quinacrine binding site is within the Kir4.1 central cavity
Previous studies showed that antidepressants like fluoxetine and nortriptyline and the compound chloroethylclonidine block Kir4.1 channels interacting with residues located in the transmembrane pore (Furutani et al., 2009; Rodriguez-Menchaca et al., 2016) . Therefore, we performed molecular modeling to define the lowest binding free energy pose for quinacrine within the conduction pathway of Kir4.1 channels. The docking results show that quinacrine interacts with Kir4.1 channels through hydrogen-bonds and hydrophobic contacts ( Fig. S2 and Table S1 ). In the lowest energy pose, the positively charged alkylamino nitrogen (N3) of quinacrine interacts with the glutamic acid side chains at position 158 (Glu158 from subunit A) forming a salt bridge. Additionally, three hydrogen-bonds are formed between quinacrine and Kir4.1 channels. The quinoline ring nitrogen (N5) of quinacrine interacts with the residue Glu158 (subunit B) of Kir4.1, and the residues Thr127 (subunit D) and Thr128 (subunit D) interact with the alkylamino nitrogen (N4) of quinacrine (Fig. S2) . The backbone oxygen atom of T127 seems to form the hydrogen-bond with the nitrogen (N4) in the Qn molecule (Fig. S2) . From these results, we generated three point mutations on Kir4.1 channels (E158N, T127A and T128A) to test the effect of quinacrine on excised inside-out patches. Fig. 4A -D shows the effect of 10 μM quinacrine on Kir4.1 WT and mutant channels. The patch was held at −80 mV, and a voltage step to +80 mV for 50 s was applied followed by a 45 s pulse to −80 mV. In WT channels, 10 μM quinacrine inhibited 88.3 ± 1.5 % of the outward currents. Similar results were obtained with the T127A mutation (89.7 ± 1.1 %), whereas in the mutants T128A (66.1 ± 1.1 %) and E158N (79.8 ± 2.2 %) the inhibition was significantly reduced (Fig. 4E) . Additionally, the unblocking of quinacrine in the E158N mutant was clearly accelerated (Fig. 4D) , indicating that this residue is very important for the stabilization of quinacrine within the Kir4.1 pore.
Finally, taking into account our experimental data, the 3D binding model of quinacrine within the Kir4.1 channel cavity is shown in Fig. 5 . This model depicts the transmembrane domain of the channel, showing only three subunits, A, B, and D.
Discussion
Kir4.1 is an inwardly rectifying K + channel highly expressed in glia and kindney. In glial cells, Kir4.1 has been implicated in several functions including extracellular K + homeostasis, maintenance of the resting potential, cell volume regulation, and facilitation of glutamate uptake (Nwaobi et al., 2016) . In kidney, Kir4.1 plays a role in K + recycling across the basolateral membrane in corresponding nephron segments and in generating negative membrane potential (Palygin et al., 2016) . Therefore, modulating Kir4.1 channels activity would influence the function of these important systems.
In this study, we examined the effect of quinacrine on Kir4.1 channels expressed in HEK293 cells. Quinacrine inhibited Kir4.1 channels in a concentration-and voltage-dependent manner and with extremely slow blocking and unblocking kinetics. Our results indicate that the drug binds to the central cavity of the channel stabilized primarily by a glutamic acid at position 158 with the contribution of the residue T128.
In our whole-cell experiments (Fig. 1) , quinacrine strongly inhibited outward and inward Kir4.1 currents. However, the inward currents showed a slow time-dependent recovery as a result of the slow quinacrine dissociation from the channels. Therefore, a long hyperpolarizing pulse was required to fully recover the currents (Fig. 1D) . The blocking effect of quinacrine during depolarizations and its dissociation from the channels at voltages negative to E K mimic the effect of internally applied drugs (e.g., chloroquine, pentamidine, chloroethylclonidine) on Kir channels (Rodríguez-Menchaca et al., 2008; de Boer et al., 2010; Rodríguez-Menchaca et al., 2016) . It is therefore conceivable that quinacrine blocks the Kir4.1 channels from the inside after permeating into the cells. Thus, we applied quinacrine to inside-out patches expressing Kir4.1 channels. Under this condition, quinacrine blocked Kir4.1 channels during the depolarizing pulse and completely dissociated from the channels during the repolarization at all concentrations tested (Fig. 2) , suggesting that quinacrine acts on Kir4.1 channels from the inside of the plasma membrane. The Hill coefficient for the concentration-response curve of quinacrine in blocking Kir4.1 was close to one (Fig. 2D) , suggesting that quinacrine blocks Kir4.1 channels through a 1:1 interaction. This is also supported by the fact that the time constants for unblock at 30 and 100 μM of quinacrine were similar (Fig. 3C ).
Virtually all of the reported blockers of Kir4.1 bind to residues of the central cavity of the channel (Furutani et al., 2009; Rodriguez-Menchaca et al., 2016) . In this work, we performed molecular modeling followed by mutagenesis studies to identify the site of interaction of quinacrine. Similar to antidepressants and chloroethylclonidine (Furutani et al., 2009; Rodriguez-Menchaca et al., 2016 ), quinacrine appears to interact with residues of the central cavity of Kir4.1. The positively charged alkylamino nitrogen of quinacrine forms a salt bridge with the glutamic acid side chains at position 158 (E158). Additionally, three hydrogen-bonds are formed between quinacrine and Kir4.1 (Fig. S2 and Table S1 ). Furthermore, E158 seems to be responsible for the slow unblocking kinetics of quinacrine from Kir4.1 channels (Fig. 3C ) since its neutralization accelerated this process (Fig. 4D) . These results suggest that E158 is the most important residue for quinacrine interaction, yet the mutant T128A had the biggest effect on quinacrine block.
Contrary to quinacrine, we previously showed that chloroethylclonidine blocks Kir4.1 channels with very fast kinetics (Rodríguez-Menchaca et al., 2016) . Although these drugs are positively charged at physiological pH and both interact with residues of the central cavity of the channel (T128 and E158), quinacrine is a bulkier molecule compared to chloroethylclonidine (Fig. S3 ). This could explain the differences in the blocking and unblocking kinetics between these drugs.
It has been reported that quinacrine inhibits Kir2.x and Kir6.2 channels by a fast-onset poreblock and also by a slow-onset PIP 2 -interference mechanisms (Lopez-Izquierdo et al., 2011) . Here, given the extremely slow kinetics of quinacrine unblock on Kir4.1 channels (τ ~ 9 s), we cannot ruled out the possibility that quinacrine disrupts the PIP 2 -Kir4.1channel interaction. Even though, since Kir4.1 channels have the strongest affinity for PIP 2 out of all the Kir channels (Du et al., 2004) , it would be expected that Kir4.1 currents are less inhibited by PIP 2 -sequestring drugs.
There are many potential consequences if Kir4.1 is absent or dysfunctional within the brain (Djukic et al., 2007; Kucheryavykh et al., 2007; Haj-Yasein et al., 2011) . It has been suggested that dysfunction of Kir4.1 channels disrupt spatial K + buffering by astrocytes, elevates extracellular levels of K + and glutamate and causes abnormal excitation of neurons, leading to an increased seizure activity (Djukic et al., 2007; Kucheryavykh et al., 2007) . In this context, the inhibition of Kir4.1 by pore blocking drugs could also induce these abnormalities.
Quinacrine is able to accumulate in mice brains at concentrations nearly 1 μM (Ghaemmaghami et al., 2009 ). This value represents the quinacrine concentration in a brain homogenate. However, the intracellular concentration of quinacrine is typically 30 to 50 times higher than its extracellular concentration (Gayrard et al., 2005) . The IC 50 for inhibition of Kir4.1 channels by quinacrine was 1.8 ± 0.3 μM (Fig. 4D) , a concentration lightly above the brain concentrations reported in animal models (Huang et al., 2006; Ghaemmaghami et al., 2009) . Some side effects of quinacrine have been reported affecting the central nervous system, including restlessness, vertigo, insomnia, nightmares, hyperirritability, psychosis, and seizures (Borda and Krant, 1967; Jaeger et al., 1987; Nash et al., 2001 , Ehsanian et al, 2011 . Particularly, seizures could be related to its effect on Kir4.1 channels. Even though, further studies are required to elucidate the relation between Kir4.1 blockade and the development of seizures.
Conclusion
This study demonstrated that quinacrine causes a concentration-and voltage dependent block of Kir4.1 by interacting with residues of the central cavity of the channel. Although is unclear at present, the blockade of Kir4.1 channels could have significant clinical consequences.
Experimental procedure
Molecular Biology and Cell Transfection
The cDNA encoding the rat Kir4.1 subunit (kind gift from C. G. Nichols, Washington University, St. Louis, MO, USA) was subcloned into the mammalian expression vector pcDNA3.1 (Invitrogen, Carlsbad, CA, USA). Mutations were made using the QuikChange Site-Directed Mutagenesis kit (Stratagene, La Jolla, CA, USA). All mutations were confirmed by direct DNA sequencing. HEK293 cells were transiently transfected with WT and mutant Kir4.1 plasmids using Lipofectamine 2000 reagent (Invitrogen) according to manufacturer's instructions. A total of 5 μg cDNA was transfected for inside-out and 10 ng for whole-cell experiments.
Current recordings in HEK293 cells
Macroscopic currents were recorded in the whole-cell and inside-out configurations of the patch clamp technique by using an Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA, USA). Data acquisition and command potentials were controlled by the pClamp 9.0 software (Molecular Devises). Patch pipettes with a resistance of 1 to 2 MΩ were made from borosilicate capillary glass (World Precision Instruments, Saratosa, FL, USA). Currents were filtered with a four-pole Bessel filter at 1 kHz and digitized at 5 kHz. An agar-KCl bridge was used to ground the bath.
For whole-cell recordings, pipettes were filled with the internal solution that contained (in mM): 110 KCl, 10 HEPES, 5 K 4 BAPTA, 5 K 2 ATP and 1 MgCl 2 ; pH 7.2. The bath solution contained (in mM): 104 NaCl, 30 KCl, 1.8 CaCl 2 , 1 MgCl 2 , 10 HEPES and 10 glucose; pH 7.4. The currents are represented as the current sensitive to block by 10 mM BaCl 2 . Insideout patches were recorded by using a Mg 2+ -and polyamine-free solution on both sides of the patch containing the following: 123 mM KCl, 5 mM K 2 EDTA, 7.2 mM K 2 HPO 4 and 8 mM KH 2 PO 4 , pH 7.2. To prevent current rundown, K + -fluoride, K + -vanadate and K + -pyrophosphate were added (Huang et al., 1998) . The pH 5.0 condition was sufficient to abolish any detectable current through Kir channels, and off-line subtraction of the pH 5.0 currents was used to subtract endogenous and leak currents prior analysis to avoid an underestimation of the quinacrine potency. All the current traces shown in the paper were corrected for endogenous and leak currents (Fig. S1 ). In all cases the endogenous/leak currents were less than 3% of the total current.
Drugs
Quinacrine (Sigma-Aldrich, St. Louis, MO, USA) was dissolved directly in the solutions at the desired concentration. HEK-293 cells were exposed to quinacrine solutions until the steady-state effects were obtained, using a Fast-Step Perfusion System (VC-77SP Warner Instruments, Hamden, CT, USA).
Molecular modeling and ligand docking
Homology models of Kir4.1 channel were built based on a crystal structure of Kir2.2 channel (PDBID: 3SPI) template. Sequence alignment between Kir4.1 and Kir2.2 channels was generated by ClustalW server (http://www.genome.jp/tools/clustalw/). The MODELLER program (Sali and Blundell, 1993) was used to generate ten initial Kir4.1 channel homology models based on the Kir2.2 structure template, and the one with the best internal DOPE sore of the program was selected for predicting quinacrine and the channel interactions.
An automatic molecular docking program, AUTODOCK4.2 (Morris et al., 1998) , was used for the docking of quinacrine into the structure of Kir4.1 channel. The AutoDockTools (ADT) was used for the docking simulation setup. The partial atomic charges for quinacrine were calculated using the Gasteiger-Marsili method (Gasteiger and Marsili, 1980) . The grid potential maps were generated for the Kir4.1 channel using CHNOCl (i.e., carbon, hydrogen, nitrogen, oxygen and chloride) elements sampled on a uniform grid containing 100 × 100 × 100 points, 0.375 Å apart. The center of the grid box was set to a cluster of residues, E158 and T128 of the channel. The Lamarckian Genetic Algorithm (LGA) was selected to identify the binding conformations of the ligand. Twenty docking simulations were performed and the final docked quinacrine configuration was selected on the basis of docked binding energies.
The predicted quinacrine-Kir4.1 channel complex was further optimized by SYBYL program using a distance-dependent dielectric constant of 5 to simulate the solvation effect in protein environment (Mehler and Solmajer, 1991) . The detailed quinacrine-Kir4.1 channel interactions were analyzed by using LIGPLOT program (Wallace et al., 1995) .
Data Analysis
Patch-clamp data were processed by using Clampfit 9.0 (Molecular Devices) and then analyzed in Origin 7 (OriginLab Corp., Northampton, MA, USA). Data are presented as mean ± SEM. (n = number of cells or patches).
The fractional block of current (f) was plotted as a function of drug concentration ([D] ), and the data were fitted with a Hill equation: f = 1/{1 + (IC 50 )/[D] nh }, to determine the IC 50 and the Hill coefficient, nh. Statistical significance was evaluated by Student's t test or ANOVA followed by Dunnett's test. Differences were considered significant at p<0.05.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. Molecular model of Kir4.1 channel binding pocket with docked Qn. The Kir4.1 channel model is shown in NewCartoon presentation (subunits A, B, and D are in blue, yellow, and orange, respectively. The subunit C was removed for clarity). The Qn is drawn in Licorice, and interacting residues with Qn are drawn in VDW sphere.
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